28.05.2015
- AbbVie has completed the acquisition of Pharmacyclics, a deal the Chicago-based US drugmaker says enhances its scientific and commercial presence in oncology. As a wholly owned...
05.03.2015
- US drugmaker AbbVie has reached final agreement to acquire compatriot Pharmacyclics and the company's flagship asset Imbruvica (ibrutinib), which it describes as "a highly...
